Fibronectin aggregation in multiple sclerosis lesions impairs remyelination

Brain

Volumn 136, Issue 1, 2013, Pages 116-131

  Stoffels, Josephine M J ^a   De Jonge, Jenny C ^a   Stancic, Mirjana ^a   Nomden, Anita ^a   Van Strien, Miriam E ^b   Ma, Dan ^c   Šišková, Zuzana ^a   Maier, Olaf ^a   Ffrench Constant, Charles ^d   Franklin, Robin J M ^c   Hoekstra, Dick ^a   Zhao, Chao ^c   Baron, Wia ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

astrocyte; fibronectin; multiple sclerosis; oligodendrocyte; remyelination

Indexed keywords

FIBRONECTIN; LIPOPOLYSACCHARIDE; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CENTRAL NERVOUS SYSTEM; CIRCULATION; CONTROLLED STUDY; DEMYELINATION; ENCEPHALITIS; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT; RELAPSE; REMYELINIZATION;

EID: 84873345336     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws313     Document Type: Article

References (62)

1. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligo-dendrocyte progenitor maturation. Nat Med 2005; 11: 966-72.
2. Baneyx G, Baugh L, Vogel V. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc Natl Acad Sci USA 2002; 99: 5139-43.
3. Baron W, Colognato H, Ffrench-Constant C. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 2005; 49: 467-79.
4. Baron W, Decker L, Colognato H, Ffrench-Constant C. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol 2003; 13: 151-5.
5. Blakemore WF, Franklin RJM. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 2008; 318: 193-212.
6. Bsibsi M, Nomden A, van Noort JM, Baron W. Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formation. J Neurosci Res 2012; 90: 388-98.
7. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61: 1013-21.
8. Buttery PC, Ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999; 3: 199-212.
9. Chari DM, Zhao C, Kotter MR, Blakemore WF, Franklin RJ. Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system. J Neurosci Res 2006; 83: 594-605.
10. Chen R, Gao B, Huang C, Olsen B, Rotundo RF, Blumenstock F, et al. Transglutaminase-mediated fibronectin multimerization in lung endothelial matrix in response to TNF-a. Am J Physiol Lung Cell Mol Physiol 2000; 27: L161-74.
11. Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, Georges-Labouesse E, et al. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 2002; 4: 833-41.
12. Colognato H, Ffrench-Constant C, Feltri ML. Human diseases reveal novel roles for neural laminins. Trends Neurosci 2005; 28: 480-86.
13. de Jong EK, Dijkstra IM, Hensens M, Brouwer N, van Amerongen M, Liem RS, et al. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J Neurosci 2005; 17: 7548-57.
14. Duncan ID, Brower A, Kondo Y, Curlee JF Jr, Schultz RD. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci USA 2009; 106: 6832-6.
15. Fancy SPJ, Zhao C, Franklin RJM. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte precursor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 2004; 27: 247-54.
16. Franklin RJ, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839-55.
17. Furlan R, Cuomo C, Martino G. Animal models of multiple sclerosis. Methods Mol Biol 2009; 549: 157-73.
18. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009; 72: 1914-21.
19. Gutowski NJ, Newcombe J, Cuzner ML. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling. Neuropathol Appl Neurobiol 1999; 25: 207-14.
20. Johnson KJ, Sage H, Briscoe G, Erickson HP. The compact conformation of fibronectin is determined by intramolecular ionic interactions. J Biol Chem 1999; 274: 15473-9.
21. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70: 532-40.
22. King VR, McBride A, Priestley JV. Immunohistochemical expression of the alpha5 integrin subunit in the normal adult rat central nervous system. J Neurocytol 2001; 30: 243-52.
23. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008; 131: 1749-58.
24. Ledeboer A, Wierinckx A, Bol J, Floris S, Renardel de Lavalette C, De Vries HE, et al. Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J Neuroimmunol 2003; 136: 94-103.
25. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A. The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskeleton 1999; 17: 118-32.
26. Liesi P, Dahl D, Vaheri A. Laminin is produced by early rat astrocytes in primary culture. J Cell Biol 1983; 96: 920-4.
27. Liesi P, Kaakkola S, Dahl D, Vaheri A. Laminin is induced in astrocytes of adult brain by injury. EMBO J 1984; 3: 683-6.
28. Liesi P, Kirkwood T, Vaheri A. Fibronectin is expressed by astrocytes cultured from embryonic and early postnatal brain. Exp Cell Res 1986; 163: 175-85.
29. Maier O, Baron W, Hoekstra D. Reduced raft-association of NF155 in active MS-lesions is accompanied by the disruption of the paranodal junction. Glia 2007; 55: 885-95.
30. Maier O, van der Heide T, van Dam AM, Baron W, de Vries H, Hoekstra D. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis? Mol Cell Neurosci 2005; 28: 390-401.
31. Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 2005; 24: 389-99.
32. McKeown-Longo PJ, Mosher DF. Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol 1983; 100: 364-74.
33. Milner R, Crocker SJ, Hung S, Wang X, Frausto RF, del Zoppo GJ. Fibronectin-and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins x5b1 and vb5. J Immunol 2007; 178: 8158-67.
34. Morla A, Zhang Z, Ruoslathi E. Superfibronectin is a functionally distinct form of fibronectin. Nature 1994; 367: 193-6.
35. Oh LY, Yong VW. Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between FGF and astrocyte extracellular matrix. Glia 1996; 17: 237-53.
36. Ohashi T, Erickson HP. Revisiting the mystery of fibronectin multimers: the fibronectin matrix is composed of fibronectin dimers cross-linked by non-covalent bounds. Matrix Biol 2009; 28: 170-5.
37. Pachner AR. Experimental models of multiple sclerosis. Curr Opin Neurol 2011; 24: 291-9.
38. Pasqualini R, Bourdoulous S, Koivunen E, Woods VL, Ruoslathi E. A polymeric form of fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Nat Med 1996; 2: 1197-203.
39. Peters DM, Portz LM, Fullenwider J, Mosher DF. Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures. J Cell Biol 1990; 111: 249-56.
40. Price J, Hynes RO. Astrocytes in culture synthesize and secrete a variant form of fibronectin. J Neurosci 1985; 5: 2205-11.
41. Relvas JB, Setzu A, Baron W, Buttery PC, LaFlamme SE, Franklin RJ, et al. Expression of dominant-negative and chimeric subunits reveals an essential role for beta1 integrin during myelination. Curr Biol 2001; 11: 1039-43.
42. Satoh JI, Tabunoki H, Yamamura T. Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult Scler 2009; 15: 531-41.
43. Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol 2008; 20: 565-72.
44. Sim FJ, Hinks GL, Franklin RJ. The re-expression of the homeodomain transcription factor Gtx during remyelination of experimentally induced demyelinating lesions in young and old rat brain. Neuroscience 2000; 100: 131-9.
45. Siskova Z, Baron W, Vries de H, Hoekstra D. Fibronectin impedes 'myelin sheet' directed flow in oligodendrocytes: a role for the beta 1 integrin mediated PKC signaling in vesicular trafficking. Mol Cell Neurosci 2006; 33: 150-9.
46. Siskova Z, Yong VW, Nomden A, van Strien M, Hoekstra D, Baron W. Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity. Mol Cell Neurosci 2009; 42: 234-42.
47. Sobel RA, Mitchell ME. Fibronectin in multiple sclerosis lesions. Am J Pathol 1989; 135: 161-8.
48. Sottile J, Hocking DC, Swiatek PJ. Fibronectin assembly enhances adhesion-dependent cell growth. J Cell Sci 1998; 111: 2933-43.
49. Stancic M, van Horssen J, Thijssen VL, Gabius HJ, van der Valk P, Hoekstra D, et al. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2011; 37: 654-71.
50. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8: 681-94.
51. Van Horssen J, Bö L, Dijkstra CD, de Vries HE. Extensive extracellular matrix depositions in active multiples sclerosis lesions. Neurobiol Dis 2006; 24: 484-91.
52. Van Horssen J, Bö L, Vos CM, Virtanen I, de Vries HE. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J Neuropathol Exp Neurol 2005; 64: 722-9.
53. Van Strien ME, Drukarch B, Bol JG, Van Der Valk P, Van Horssen J, Gerritsen WH, et al. Appearance of tissue transglutaminase in astro-cytes in multiple sclerosis lesions: a role in cell adhesion and migration? Brain Pathol 2011; 21: 44-54.
54. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005; 19: 1872-4.
55. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronec-tin matrix assembly. J. Cell Sci 2003; 116: 3269-76.
56. Woodruff RH, Franklin RJ. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following a stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 1999; 25: 216-28.
57. Wu C, Bauer JS, Juliano RL, McDonald JA. The The x5b1 integrin fibronectin receptor, but not the a5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem 1993; 268: 21883-8.
58. Wu C, Keivens WM, O'Toole TE, MacDonald JA, Ginsberg MH. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995; 83: 715-24.
59. Zawadzka M, Rivers LE, Fancy SPJ, Zhao C, Tripathi R, Jamen F, et al. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 2010; 6: 578-90.
60. Zhao C, Fancy SP, ffrench-Constant C, Franklin RJ. Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redunant role in remyelination. Neurobiol Dis 2008; 31: 209-17.
61. Zhao C, Fancy SP, Franklin RJM, ffrench-Constant C. Up-regulation of oligodendrocyte precursor cell av integrin and its extracellular ligands during central nervous system remyelination. J Neurosci Res 2009; 87: 3447-55.
62. Zhao C, Li WW, Franklin RJ. Differences in the early inflammatory response to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol Aging 2006; 27: 1298-1307.